Publicaciones en las que colabora con ELIZABETH HIJONA MURUAMENDIARAZ (13)

2019

  1. Pterostilbene reduces liver steatosis and modifies hepatic fatty acid profile in obese rats

    Nutrients, Vol. 11, Núm. 5

2018

  1. The dietary antioxidant piceatannol inhibits adipogenesis of human adipose mesenchymal stem cells and limits glucose transport and lipogenic activities in adipocytes

    International Journal of Molecular Sciences, Vol. 19, Núm. 7

2017

  1. Pterostilbene-induced changes in gut microbiota composition in relation to obesity

    Molecular Nutrition and Food Research, Vol. 61, Núm. 1

2016

  1. Effects of pterostilbene in brown adipose tissue from obese rats

    Journal of Physiology and Biochemistry, Vol. 73, Núm. 3, pp. 457-464

  2. Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects

    Journal of Physiology and Biochemistry, Vol. 72, Núm. 3, pp. 567-582

  3. Potential renoprotective effects of piceatannol in ameliorating the early-stage nephropathy associated with obesity in obese Zucker rats

    Journal of Physiology and Biochemistry, Vol. 72, Núm. 3, pp. 555-566

2014

  1. Effects of resveratrol and other polyphenols in hepatic steatosis

    World Journal of Gastroenterology, Vol. 20, Núm. 23, pp. 7366-7380

  2. Novel equation to determine the hepatic triglyceride concentration in humans by MRI: Diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery

    BMC Medicine, Vol. 12, Núm. 1

2013

  1. Effects of resveratrol on obesity-related inflammation markers in adipose tissue of genetically obese rats

    Nutrition, Vol. 29, Núm. 11-12, pp. 1374-1380

  2. Several statins increase body and liver fat accumulation in a model of metabolic syndrome

    Journal of Physiology and Pharmacology, Vol. 64, Núm. 3

2012

  1. Accurate fat fraction quantification by multiecho gradient-recalled-echo magnetic resonance at 1.5 T in rats with nonalcoholic fatty liver disease

    European Journal of Radiology, Vol. 81, Núm. 6, pp. 1122-1127

  2. Effect of neoadjuvant chemotherapy in hepatic steatosis

    Chemotherapy, Vol. 58, Núm. 2, pp. 89-94

  3. Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress

    British Journal of Nutrition, Vol. 107, Núm. 2, pp. 202-210